PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of mayoclinprocLink to Publisher's site
 
Mayo Clin Proc. 2010 June; 85(6): 595.
PMCID: PMC2878265

CORRECTIONS

Incorrect time frame: In the article by Tosh et al entitled “Influenza Vaccines: From Surveillance Through Production to Protection,” published in the March 2010 issue of Mayo Clinic Proceedings (Mayo Clin Proc. 2010;85(3):257-273), the time frame was incorrect on page 267, lines 1 through 6, right-hand column. The sentence should read as follows: Because its safety in this population is uncertain, LAIV [live-attenuated influenza vaccine] is not currently recommended for use in people with asthma; a randomized trial found an increase in clinically relevant wheezing among those younger than 24 months in the 42 days after receiving LAIV, regardless of whether they had asthma.125

Tosh et al also want to point out that this same trial found that the increase in medically wheezing was primarily seen in weeks 2 through 4 after vaccination.


Articles from Mayo Clinic Proceedings are provided here courtesy of The Mayo Foundation for Medical Education and Research